Related Experiment Video
Updated: Jan 20, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Feasibility and Tolerability of Vamana Dhauti as an Add-On Treatment in Patients with Depression: A Pilot Randomised
Aditi Garg1, Kankan Gulati1, Nishitha Jasti1
1Department of Integrative Medicine, NIMHANS, Bengaluru, Karnataka, India.
Background:
Depression is a prevalent mental health disorder and a significant contributor to disability adjusted life years. It is also associated with increased cardiovascular risk, often not adequately addressed by current treatments, leading to significant gaps in the treatment. Yoga practices like Vamana Dhauti could be a potential adjunct therapy to standard treatments by balancing doshas and positively influencing vagal tone.
Objective:
This pilot randomised controlled trial aimed to assess the feasibility and tolerability of Vamana Dhauti in depression patients and its effects on Heart Rate Variability (HRV). Clinical changes were evaluated using the Hamilton Rating Scale for Depression (HAM-D).
Methods:
The study was conducted at the Department of Integrative Medicine, NIMHANS, Bengaluru. Patients with depression, aged 18-50 years, both genders, and no contraindications to Vamana Dhauti, were randomly assigned to Vamana Dhauti + Shavasana (n = 12) or Shavasana rest only (n = 12) groups using online software, which also included allocation concealment. Outcome measures include feasibility (acceptability, demand, practicality, adaptation, integration, perceived ease, and difficulty), tolerability (adverse events), HRV and HAM-D.
Results:
Vamana Dhauti was found feasible and tolerable in patients diagnosed with depression. Vamana Dhauti was well-accepted, could be completed within the given setting and time, and was found to be easy to practice by participants (VAS = 2 ± 1.65; 0 being very easy and 10 being very difficult) with few mild adverse events (n = 2/12). Notably, a significant group × time interaction was observed in HRV, low-frequency measures [F (1,22) = 8.168; p = .009)]. Both groups saw an increase in Low-frequency during the first 10 minutes of Shavasana (control > intervention), but after 20 minutes, only the intervention group returned to baseline values, showing improved resilience. Clinical outcomes measured by HAM-D showed a significant improvement in both groups.
Conclusion:
Vamana Dhauti is feasible and well-tolerated by patients diagnosed with depression, suggesting its potential integration into depression-focused Yoga modules.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
06:28E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Pilot Testing
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression